The reaction between bromine and (E)-1-trimethylsilylcyclo-octene
作者:Dashyant Dhanak、Colin B. Reese、David E. Williams
DOI:10.1039/c39840000988
日期:——
when (E)-1-trimethylsilycyclo-octene (4) is treated with bromine in dichloromethane solution at –78 °C and the products are allowed to warm up to room temperature, (Z)-1-brimocyclo-oct-4-ene (5) is obtaine and can be isolated in ca. 70% yield.
[EN] CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES<br/>[FR] DERIVES DE CYCLOOCT-(EN-)YL DESTINES A ETRE UTILISES COMME PARFUMS
申请人:GIVAUDAN SA
公开号:WO2004035017A1
公开(公告)日:2004-04-29
This invention relates to substituted cyclooctenes of formula (I), wherein X and R are defined in the specification.
该发明涉及式(I)的取代环辛烯,其中X和R在规范中定义。
Triethylamine Tris-hydrofluoride [(C<sub>2</sub>H<sub>5</sub>)<sub>3</sub>N·3HF]: A Highly Versatile Source of Fluoride Ion for the Halofluorination of Alkenes
作者:Gérard Alvernhe、André Laurent、Günter Haufe
DOI:10.1055/s-1987-28004
日期:——
The combination N-halosuccinimide/triethylamine tris-hydrofluoride is presented as a convenient reagent for halofluorination of alkenes.
N-卤代苏胺/三乙胺三氟化物的组合被提出作为一种方便的试剂,用于烯烃的卤氟化反应。
[EN] COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE<br/>[FR] COMPOSÉS POUR LIBÉRATION DE CHIMIE CLICK RAPIDE ET EFFICACE
申请人:TAGWORKS PHARMACEUTICALS B V
公开号:WO2020256546A1
公开(公告)日:2020-12-24
The invention disclosed herein relates to compounds, combinations, kits, and methods using same, for use in bioorthogonal release reactions. In particular, the compounds, combinations and kits of the invention can be used to achieve fast and efficient click release. Applications of the compounds, combinations, and kits of the invention include both in vitro and in vivo applications.
[EN] CHANNEL PROTEIN ACTIVATABLE LIPOSOMES<br/>[FR] LIPOSOMES ACTIVABLES PAR DES PROTÉINES DE CANAL
申请人:TAGWORKS PHARMACEUTICALS B V
公开号:WO2014081300A1
公开(公告)日:2014-05-30
Disclosed is a liposome, comprising a lipid bilayer enclosing a cavity, wherein the bilayer comprises a channel protein releasably linked to an eight-membered non-aromatic cyclic alkenylene group, preferably a cyclooctene group, and more preferably a trans-cyclooctene group. The liposomes are used in a kit comprising the liposome, the liposomal membrane of which comprises a channel protein linked to a Trigger, and an Activator for the Trigger, wherein the Trigger comprises the eight- membered non-aromatic cyclic alkenylene group, and the Activator comprises a diene.